Other Doctor Locations

Dr. Beth Safirstein
Share

Co-President of MD Clinical

Beth Safirstein, M.D. is Co-President for MD Clinical, a leading research center in South Florida that specializes in clinical trials for diseases of the central nervous system. Dr. Safirstein is a board-certified Neurologist and Principal Investigator for trials involving patients with Alzheimer's disease, Parkinson's disease, Painful Neuropathy, depression, anxiety, and primary insomnia to name a few (all in different stages of development).

In addition to her clinical investigatory work, Dr. Safirstein has served on review and advisory boards for Jackson Memorial Hospital, Forest Laboratories, GlaxoSmithKline, and the University of Miami's Department of Neurology. She is an accomplished academic physician with published works in Alzheimer's & Dementia, Movement Disorders, Sleep Medicine, Pain, Journal of Pain, Neurology and Stroke, in addition to being the recipient of several awards for the outstanding quality of her clinical and classroom performance. Cumulatively, all of this has earned Dr. Safirstein a place on the prestigious Strathmore's WHO'S WHO list every year since 2000.

Dr. Safirstein earned her doctorate at Indiana University School of Medicine and completed her residency at the University of Miami (Fla.) School of Medicine where she was the Administrative Chief Resident in Neurology. While Administrative Chief Resident in Neurology at the University of Miami, she was recognized for her outstanding work conducted through an educational grant by the American Academy of Neurology (AAN) and received the George Paff teaching award from the University of Miami, School of Medicine. She received her certification in Neurology in 2001 from the American Board of Psychiatry and Neurology and went on to earn a certification in Investigator Training for Medical Research from the University of Rochester School of Medicine in 2002.

Dr. Safirstein is a member of the American Academy of Sleep Medicine, the American Academy of Neurology, the Association of Clinical Research Professionals, and the Drug Industry Association.

Dr. Safirstein's research study is now enrolling those with mild Alzheimer's disease. No insurance is needed to participate. Click here or call toll free 844-374-2956.